Skip to main content
Top
Published in: Supportive Care in Cancer 5/2005

01-05-2005 | Original Article

Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports

Authors: Jo Caers, Christel Fontaine, Vincent Vinh-Hung, Johan De Mey, Gerrit Ponnet, Chris Oost, Jan Lamote, Jacques De Greve, Benjamin Van Camp, Patrick Lacor

Published in: Supportive Care in Cancer | Issue 5/2005

Login to get access

Abstract

Aims

The use of subcutaneous infusion ports has become standard practice to provide a long-term venous access in oncological patients. The aim of this retrospective study was to assess the different complications of infusion ports in our population and to identify predisposing factors.

Patients and methods

We reviewed the medical records of 437 patients who were followed at the Oncology/Haematology Department of our hospital. Of these patients, there were 370 (84.4%) with solid tumours and 58 (13.2%) with haematological disease. The position of the catheter tip was evaluated by reviewing the available chest radiographs or phlebographies.

Main results

Analysis of the records showed that 346 patients (79.17%) had no complications. The most common complications after implantation were thrombosis (8.46%), catheter dysfunction (4.8%) and infections (4.4%). Univariate and multivariate analysis showed that catheter tip positioning was the most important predisposing risk factor for thrombosis. Catheter tips positioned in the brachiocephalic vein or in the cranial part of the superior vena cava were associated with a high risk of thrombosis. Other significant risk factors were gender and initial diagnosis. Female patients and patients with lung cancer also had an elevated risk of developing a thrombosis.

Conclusions

Compared to other reports, we noted a higher rate of thrombosis and port dysfunction. Since catheter tip position was a predisposing factor for developing a thrombosis, correct catheter position has to be ensured during placement. Prophylactic antithrombotic treatment might be beneficial in the event of failure to position the catheter correctly.
Literature
1.
go back to reference Anderson AJ, Krasnow SH, Boyer MW, Cutler DJ, Jones BD, Citron ML, Ortega LG, Cohen MH (1989) Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 95:71–75PubMed Anderson AJ, Krasnow SH, Boyer MW, Cutler DJ, Jones BD, Citron ML, Ortega LG, Cohen MH (1989) Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 95:71–75PubMed
2.
go back to reference Barrios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP (1992) Evaluation of an implantable venous access system in a general oncology population. Oncology 49:474–478PubMed Barrios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP (1992) Evaluation of an implantable venous access system in a general oncology population. Oncology 49:474–478PubMed
3.
go back to reference Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, Greco FA, Huberman M, Moore C (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112:423–428PubMed Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, Greco FA, Huberman M, Moore C (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112:423–428PubMed
4.
go back to reference Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B (1998) Totally implantable venous access ports for long term chemotherapy. Ann Oncol 9:767–773CrossRefPubMed Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B (1998) Totally implantable venous access ports for long term chemotherapy. Ann Oncol 9:767–773CrossRefPubMed
5.
go back to reference Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D, Mahendra P, Baglin T, Marcus R (1998) Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 101:483–486CrossRefPubMed Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D, Mahendra P, Baglin T, Marcus R (1998) Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 101:483–486CrossRefPubMed
6.
go back to reference Brown-Smith JK, Stoner MH, Barley ZA (1990) Tunnelled catheter thrombosis: factors related to incidence. Oncol Nurs Forum 17:543–549PubMed Brown-Smith JK, Stoner MH, Barley ZA (1990) Tunnelled catheter thrombosis: factors related to incidence. Oncol Nurs Forum 17:543–549PubMed
7.
go back to reference Chevrel JP, Destable MD, Breau JL, Dilin C (1988) Boitiers de perfusion implantables. Presse Med 17:17–20PubMed Chevrel JP, Destable MD, Breau JL, Dilin C (1988) Boitiers de perfusion implantables. Presse Med 17:17–20PubMed
8.
go back to reference De Cicco M, Matovic M, Balestreri L, De Angelis V, Fracasso A, Morassut S, Coran F, Babare R, Buonadonna A, Testa V (1995) Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients. Thromb Res 78:127–137CrossRefPubMed De Cicco M, Matovic M, Balestreri L, De Angelis V, Fracasso A, Morassut S, Coran F, Babare R, Buonadonna A, Testa V (1995) Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients. Thromb Res 78:127–137CrossRefPubMed
9.
go back to reference De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, Testa V (1997) Central venous thrombosis: an early and frequent complication in cancer patients bearing long term silastic catheter. A prospective study. Thromb Res 86:101–113CrossRefPubMed De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, Testa V (1997) Central venous thrombosis: an early and frequent complication in cancer patients bearing long term silastic catheter. A prospective study. Thromb Res 86:101–113CrossRefPubMed
10.
go back to reference Debets JM, Wils JA, Schlangen JT (1995) A rare complication of implanted central venous access devices: catheter fracture and embolization. Support Care Cancer 3:432–434PubMed Debets JM, Wils JA, Schlangen JT (1995) A rare complication of implanted central venous access devices: catheter fracture and embolization. Support Care Cancer 3:432–434PubMed
11.
go back to reference Devie-Hubert I, Carlier M, Pozzo Di Borgo C (1996) Les thromboses veineuses sur catheter central en cancerologie. Rev Med Interne 17:821–825PubMed Devie-Hubert I, Carlier M, Pozzo Di Borgo C (1996) Les thromboses veineuses sur catheter central en cancerologie. Rev Med Interne 17:821–825PubMed
12.
go back to reference Eastridge BJ, Lefor AT (1995) Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13:233–238PubMed Eastridge BJ, Lefor AT (1995) Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13:233–238PubMed
13.
go back to reference Guenier C, Nogaret JM, Ferreira J, Lorent I, Pector JC (1990) Voies d’abord veineux en oncologie par chambe implantable. Ann Chir 44:388–391PubMed Guenier C, Nogaret JM, Ferreira J, Lorent I, Pector JC (1990) Voies d’abord veineux en oncologie par chambe implantable. Ann Chir 44:388–391PubMed
14.
go back to reference Horne MK 3rd, May DJ, Alexander HR, Steinhaus EP, Whitman ED, Chang RC, Doppman JL (1995) Venographic surveillance of tunnelled venous access devices in adult oncology patients. Ann Surg Oncol 2:174–178PubMed Horne MK 3rd, May DJ, Alexander HR, Steinhaus EP, Whitman ED, Chang RC, Doppman JL (1995) Venographic surveillance of tunnelled venous access devices in adult oncology patients. Ann Surg Oncol 2:174–178PubMed
15.
go back to reference Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW (1998) Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 22:12–16 Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW (1998) Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 22:12–16
16.
go back to reference Lagro SW, Verdonck LF, Borel Rinkes IH, Dekker AW (2000) No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients. Bone Marrow Transplant 26:1103–1106CrossRefPubMed Lagro SW, Verdonck LF, Borel Rinkes IH, Dekker AW (2000) No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients. Bone Marrow Transplant 26:1103–1106CrossRefPubMed
17.
go back to reference Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK (1985) Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42:296–300PubMed Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK (1985) Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42:296–300PubMed
18.
go back to reference Lokich JJ, Becker B (1983) Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 52:1586–1589PubMed Lokich JJ, Becker B (1983) Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 52:1586–1589PubMed
19.
go back to reference Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, Chan AK, Andrew M (2003) An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 109:101–108CrossRefPubMed Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, Chan AK, Andrew M (2003) An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 109:101–108CrossRefPubMed
20.
go back to reference Mismetti P, Mille D, Laporte S, Charlet V, Buchmuller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C, Decousus H; CIP Study Group (2003) Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 88:67–73 Mismetti P, Mille D, Laporte S, Charlet V, Buchmuller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C, Decousus H; CIP Study Group (2003) Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 88:67–73
21.
go back to reference Monreal M, Lafoz E, Ruiz J, Valls R, Alastrue A (1991) Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest 99:280–283PubMed Monreal M, Lafoz E, Ruiz J, Valls R, Alastrue A (1991) Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest 99:280–283PubMed
22.
go back to reference Monreal M, Raventos A, Lerma R, Ruiz J, Lafoz E, Alastrue A, Llamazares JF (1994) Pulmonary embolism in patients with upper extremity DVT associated to venous central lines—a prospective study. Thromb Haemost 72:548–550PubMed Monreal M, Raventos A, Lerma R, Ruiz J, Lafoz E, Alastrue A, Llamazares JF (1994) Pulmonary embolism in patients with upper extremity DVT associated to venous central lines—a prospective study. Thromb Haemost 72:548–550PubMed
23.
go back to reference Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, Abad A (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices—prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75:251–253PubMed Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, Abad A (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices—prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75:251–253PubMed
24.
go back to reference Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712PubMed Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712PubMed
26.
go back to reference Puel V, Caudry M, Le Metayer P, Baste JC, Midy D, Marsault C, Demeaux H, Maire JP (1993) Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 72:2248–2252PubMed Puel V, Caudry M, Le Metayer P, Baste JC, Midy D, Marsault C, Demeaux H, Maire JP (1993) Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 72:2248–2252PubMed
27.
go back to reference Puig-la Calle J Jr, Lopez Sanchez S, Piedrafita Serra E, Allende Honorato L, Artigas Raventos V, Puig la Calle J (1996) Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms. J Surg Oncol 62:273–278CrossRefPubMed Puig-la Calle J Jr, Lopez Sanchez S, Piedrafita Serra E, Allende Honorato L, Artigas Raventos V, Puig la Calle J (1996) Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms. J Surg Oncol 62:273–278CrossRefPubMed
28.
go back to reference Schwarz RE, Groeger JS, Coit DG (1997) Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 79:1635–1640CrossRefPubMed Schwarz RE, Groeger JS, Coit DG (1997) Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 79:1635–1640CrossRefPubMed
29.
go back to reference Stas M (1998) Positionering van katheter en poort, Poorten en Katheters voor langdurige I.V. therapie. Universitaire pers Leuven, Leuven Stas M (1998) Positionering van katheter en poort, Poorten en Katheters voor langdurige I.V. therapie. Universitaire pers Leuven, Leuven
Metadata
Title
Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports
Authors
Jo Caers
Christel Fontaine
Vincent Vinh-Hung
Johan De Mey
Gerrit Ponnet
Chris Oost
Jan Lamote
Jacques De Greve
Benjamin Van Camp
Patrick Lacor
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2005
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0723-1

Other articles of this Issue 5/2005

Supportive Care in Cancer 5/2005 Go to the issue

Forthcoming Meetings

Forthcoming Meetings 13/5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine